---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-035517"
form_type: "8-K"
ticker: "CARM"
cik: "0001485003"
company_name: "Carisma Therapeutics Inc."
filed_at: "2025-04-16T23:59:59+00:00"
generated_at: "2026-05-23T13:18:37.788225+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Carisma receives Nasdaq delisting notice for MVLS, MVPHS, bid price non-compliance

## Summary
- Nasdaq notified Carisma on April 10, 2025, of delisting for failing to maintain $50M MVLS by April 8, 2025 compliance deadline.
- Company also failed $15M MVPHS rule; granted 180 days until October 7, 2025, to regain compliance.
- Existing bid price non-compliance (below $1.00) has compliance period through July 7, 2025.
- Carisma plans to request a hearing before Nasdaq Panel to stay delisting; no assurance of extension.
- Company considering all options but cannot guarantee regaining compliance with any listing rule.

## SEC filing metadata
- accession: 0001104659-25-035517
- form_type: 8-K
- ticker: CARM
- cik: 0001485003
- company_name: Carisma Therapeutics Inc.
- filed_at: 2025-04-16T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1485003/000110465925035517/0001104659-25-035517-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1485003/000110465925035517/tm2512481d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-035517
- JSON: https://secwatch.observer/filing/0001104659-25-035517.json
- Plain text: https://secwatch.observer/filing/0001104659-25-035517.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.